{"id":279006,"date":"2026-09-30T09:30:37","date_gmt":"2026-09-30T04:00:37","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=279006"},"modified":"2026-10-14T13:28:58","modified_gmt":"2026-10-14T07:58:58","slug":"why-dr-reddy-s-laboratories-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-dr-reddy-s-laboratories-share-price-fall-today-2026\/","title":{"rendered":"Dr. Reddy’s Laboratories (DRREDDY) Share Price Falls 2.14% Today as Large Cap Pharma Stock Weakens"},"content":{"rendered":"
Dr. Reddy's Laboratories (DRREDDY) share price fell to Rs 1,213.15 today, down 2.14% from the previous close. Market cap was Rs 1,02,707.41 crore.<\/em><\/div>\n

Dr. Reddy’s Laboratories Share Price<\/strong> fell to Rs 1,213.15, down 2.14% from the previous close, while the company\u2019s market capitalisation stood at Rs 1,02,707.41 crore. The move makes Dr. Reddy’s Laboratories Share Price one of the more closely read market updates in the healthcare space today, especially because the stock is a Large Cap name in Pharmaceuticals & Drugs. The price move is confirmed in Univest data; a company-specific reason has not been established. As a result, Dr. Reddy’s Laboratories Share Price Today is best read through the intraday price action, the company\u2019s valuation profile and its place in the healthcare peer set. Univest is tracking the move alongside Dr. Reddy’s Laboratories Stock News and broader pharma market cues.<\/p>\n

For readers looking at Dr. Reddy’s Laboratories Share Price Today, the stock is being watched not for a storyline built on speculation, but for what the numbers show. Dr. Reddy’s Laboratories Share Price is trading lower after an intraday range that stayed tight relative to the day\u2019s gap from the previous close. That makes the share price fall relevant for stock analysis, fundamental analysis and sector analysis, particularly when compared with listed peers in the same industry. Univest data helps place the decline in context without assuming a trigger. Dr. Reddy’s Laboratories Share Price therefore remains a factual price-action event first, and a valuation and peer-comparison story second.<\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n